Appointment of Nomad & Broker

RNS Number : 0213O
Futura Medical PLC
16 September 2013
 

For immediate release

16 September 2013

 

 

 

Futura Medical plc

("Futura" or the "Company")

 

Appointment of Nominated Adviser and Broker

 

 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the appointment with immediate effect of Cenkos Securities plc as the Company's nominated adviser and broker.

 

 

 

 

For any further information please contact:

 

Futura Medical plc


James Barder, Chief Executive

 

Tel: +44 (0)1483 685 670

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 


Cenkos Securities plc


Bobbie Hilliam

Tel:+44 (0)20 7397 8900

 

 


For media enquiries please contact:




Buchanan


Mark Court / Fiona Henson / Sophie Cowles

www.buchanan.uk.com

 

Tel: +44 (0)20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPMMGMLGKVGFZZ
UK 100

Latest directors dealings